Oral brivudin versus intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: a randomized double-blind trial

Authors: Wutzler P.; Wutke K.; Farber I.; De Clercq E.

Source: Antiviral Research, Volume 26, Number 3, March 1995 , pp. 302-302(1)

Publisher: Elsevier

Language: English

Document Type: Abstract

DOI: 10.1016/0166-3542(95)94842-P

Links for this article